Skip to main content
. 2022 Oct 14;12:1023391. doi: 10.3389/fonc.2022.1023391

Figure 2.

Figure 2

IHC and immunofluorescence staining of primary breast cancer cells: BC3, BC4, BC5, BC6, BC10, and BC13. (A) IHC staining of ER, PR, and HER2 of BC3, BC4, BC5, BC6, BC10, and BC13 breast cancer tissue sections. (B) Immunofluorescence staining of ER, PR, and HER2 in the primary breast cancer cells BC3, BC4, BC5, BC6, BC10, and BC13.